MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ENGN — enGene Therapeutics Inc. Common Stock
NasdaqenGene Therapeutics Inc. Common Stock
$1.94
-0.04(-2.02%)
- O
- 2.00
- H
- 2.02
- L
- 1.93
- V
- 690.14K
⏱️ End-of-day dataAs of Oct 2, 2026
ENGN — Latest News & Headlines
2 StoriesenGene Therapeutics (Nasdaq:ENGN) - Stock Analysis - Simply Wall Street
enGene Therapeutics (Nasdaq:ENGN) - Stock Analysis Simply Wall Street
At $1.97 a share, enGene Therapeutics (ENGN) interim medical chief bought 5,102 shares. - Stock Titan
At $1.97 a share, enGene Therapeutics (ENGN) interim medical chief bought 5,102 shares. Stock Titan